Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma
Kostopoulos, Ioannis V., Ntanasis‐Stathopoulos, Ioannis, Rousakis, Pantelis, Malandrakis, Panagiotis, Panteli, Chrysanthi, Eleutherakis‐Papaiakovou, Evangelos, Angelis, Nikolaos, Spiliopoulou, Vasiliki, Syrigou, Rodanthi‐Eleni, Bakouros, Panagiotis, Dimitrakopoulou, Georgia, Fotiou, Despina, Migkou, Magdalini, Kanellias, Nikolaos, Paschalidis, Nikolaos, Gavriatopoulou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios‐Athanasios, Tsitsilonis, Ourania E., Terpos, Evangelos
Published in American journal of hematology (01.10.2024)
Published in American journal of hematology (01.10.2024)
Get full text
Journal Article
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era
Ntanasis-Stathopoulos, Ioannis, Filippatos, Charalampos, Gavriatopoulou, Maria, Malandrakis, Panagiotis, Eleutherakis-Papaiakovou, Evangelos, Spiliopoulou, Vassiliki, Syrigou, Rodanthi-Eleni, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios Athanasios, Terpos, Evangelos
Published in Diseases (01.09.2023)
Published in Diseases (01.09.2023)
Get full text
Journal Article
Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: part 1 results of a phase I/II study
Terpos, Evangelos, Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Spiliopoulou, Vasiliki, Kostopoulos, Ioannis V, Syrigou, Rodanthi-Eleni, Eleutherakis-Papaiakovou, Evangelos, Gkolfinopoulos, Stavros, Tsitsilonis, Ourania E, Kastritis, Efstathios, Dimopoulos, Meletios A
Published in Haematologica (Roma) (01.08.2024)
Published in Haematologica (Roma) (01.08.2024)
Get full text
Journal Article
P-477 Pre-exposure prophylaxis for COVID-19 with tixagevimab/cilgavimab (evusheld) in patients with multiple myeloma in the omicron SARS-COV-2 era
Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Eleutherakis-Papaiakovou, Evangelos, Malandrakis, Panagiotis, Spiliopoulou, Vassiliki, Syrigou, Rodanthi-Eleni, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios, Terpos, Evangelos
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
OA-13 Increased levels of circulating tumor cells correlate with adverse clinical outcomes and distinct biological features in newly diagnosed patients with multiple myeloma
Kostopoulos, Ioannis, Ntanasis-Stathopoulos, Ioannis, Rousakis, Pantelis, Malandrakis, Panagiotis, Panteli, Chrysanthi, Eleutherakis-Papaiakovou, Evangelos, Angelis, Nikolaos, Spiliopoulou, Vassiliki, Syrigou, Rodanthi-Eleni, Dimitrakopoulou, Georgia, Fotiou, Despina, Migkou, Magdalini, Gavriatopoulou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios, Tsitsilonis, Ourania, Terpos, Evangelos
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article